www.fdanews.com/articles/176026-resmed-finalizes-800m-brightree-acquisition
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GreenDollarSign.gif?t=1433864063&width=430)
ResMed Finalizes $800M Brightree Acquisition
April 5, 2016
San Diego-based ResMed has finalized its acquisition of cloud healthcare software company Brightree for $800 million, the company reported Monday in an SEC filing.
The companies announced the acquisition in February.
Brightree specializes in post-acute care-focused clinical software applications. The Atlanta-based company will keep its name and continue to operate as a separate entity. — Anisa Jibrell